Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs Lexaria Bioscience Corp. (LEXX)

Alzamend Neuro, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. Alzamend Neuro, Inc. and Lexaria Bioscience Corp. are of similar size ($6.3M and $6.2M). Across the 10 metrics below, Alzamend Neuro, Inc. leads on 7 and Lexaria Bioscience Corp. on 3.

Valuation

Metric ALZN LEXX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 8.91 9.71
P/B 1.02 1.11 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 n/m 0.64
EV/Sales n/m 2.36 9.21
Earnings yield (174.24%) (174.57%) (33.15%)
Free cash flow yield (120.83%) (155.80%) (25.50%)

Profitability

Metric ALZN LEXX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.23%) (162.60%) (56.36%)
Return on assets (122.36%) (134.20%) (48.04%)
Return on invested capital 0.00% (662.56%) 0.00%

Growth

Metric ALZN LEXX Biotechnology median
Revenue growth (TTM) — 9.08% 6.02%
EPS growth (last fiscal year) 76.77% (40.43%) 30.26%
Revenue growth, 5-year CAGR — 17.53% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN LEXX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 10.60 4.72
Net debt to EBITDA 0.08 0.17 0.96

Dividend

Metric ALZN LEXX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALZN LEXX Biotechnology median
Market cap 6.17m 6.30m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack